0001127602-15-016605.txt : 20150507
0001127602-15-016605.hdr.sgml : 20150507
20150507204539
ACCESSION NUMBER: 0001127602-15-016605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150507
FILED AS OF DATE: 20150507
DATE AS OF CHANGE: 20150507
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 15843736
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-05-07
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
Chairman & Co-CEO
Common Stock
2015-05-07
4
M
0
4115
34.56
A
4355
D
Common Stock
2015-05-07
4
S
0
4115
168.1758
D
240
D
Common Stock
2015-05-07
4
M
0
5547
30.75
A
5787
D
Common Stock
2015-05-07
4
S
0
200
166.03
D
5587
D
Common Stock
2015-05-07
4
S
0
900
167.5477
D
4687
D
Common Stock
2015-05-07
4
S
0
200
168.335
D
4487
D
Common Stock
2015-05-07
4
S
0
656
170.8567
D
3831
D
Common Stock
2015-05-07
4
S
0
400
171.6425
D
3431
D
Common Stock
2015-05-07
4
S
0
1100
173.1536
D
2331
D
Common Stock
2015-05-07
4
S
0
1291
173.927
D
1040
D
Common Stock
2015-05-07
4
S
0
800
169.6538
D
240
D
Common Stock
166
I
By Spouse
Common Stock
625031.05
I
By Trusts
Stock Options
34.56
2015-05-07
4
M
0
4115
0
D
2005-12-30
2015-12-30
Common Stock
4115
115235
D
Stock Options
30.75
2015-05-07
4
M
0
5547
0
D
2009-12-26
2017-12-31
Common Stock
5547
477007
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $167.78 to $168.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $165.57 to $166.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $167.10 to $168.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $168.23 to $168.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $170.32 to $171.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $171.36 to $172.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $172.55 to $173.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $173.59 to $173.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $169.31 to $170.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Adjusted to reflect a total of 30,644 shares originally acquired by the reporting person on 4/27/15 and 5/4/15 pursuant to "exercise and hold" transactions, which were then transferred into trusts beneficially owned by the reporting person.
Adjusted to reflect a total of 30,644 shares originally acquired by the reporting person on 4/27/15 and 5/4/15 pursuant to "exercise and hold" transactions, which were then transferred into trusts beneficially owned by the reporting person.
/s/ John S. Hess, Jr. under Power of Attorney
2015-05-07